Ketamine Therapy Myths: Debunking Misconceptions About a Widely Discussed Treatment


Clearing up confusion and offering clarity about one of the most studied tools in emerging mental health care

Introduction: What You’ve Heard vs. What’s True

As interest in psychedelic-assisted therapy grows, ketamine has emerged as one of the most researched and accessible tools in the mental health field. Originally developed as an anesthetic, ketamine is now being explored in controlled, therapeutic contexts for its potential to support emotional healing and transformation.

But with popularity comes misunderstanding.

In this article, we’ll explore and dismantle common myths surrounding ketamine therapy, offer evidence-based insights, and help you understand what the research—and real-world experience—actually shows.

Myth #1: Ketamine Therapy Is Only for People with Severe Depression

Many assume that ketamine therapy is reserved for individuals who have exhausted every other option, often referred to as “treatment-resistant depression.” While this is one of the better-studied applications, it’s not the whole picture.

Clinical research suggests that ketamine’s action on the glutamate system and BDNF (brain-derived neurotrophic factor) may support a broader population—those experiencing:

  • Persistent anxiety

  • PTSD

  • Chronic stress

  • Adjustment-related mood challenges

  • Emotional shutdown or cognitive rigidity

In these cases, ketamine may offer a neurobiological “reset,” increasing plasticity and responsiveness to therapy.

📚 Related reading:

  • Feder, A., Parides, M. K., et al. (2014). Efficacy of intravenous ketamine for treatment of chronic PTSD: A randomized clinical trial. JAMA Psychiatry.
    Link

Myth #2: Ketamine Is Addictive or Unsafe

It’s true that ketamine has been misused recreationally, which has colored public perception. But in clinical contexts, where it’s administered in sub-anesthetic doses by licensed professionals, ketamine shows no signs of dependency or compulsive use.

A 2019 review in The Lancet Psychiatry concluded that therapeutic ketamine carries minimal risk of addiction when used appropriately, and has a favorable safety profile compared to many conventional medications.

Key safety features include:

  • Medical screening prior to treatment

  • Dose protocols aligned with clinical research

  • Ongoing monitoring of physiological response

  • Supportive environment with trained professionals

Myth #3: It’s Just a Quick Fix

Yes, ketamine often works rapidly—many people experience noticeable shifts in mood or cognition within hours or days. But lasting results depend on what happens next.

Ketamine is best understood as a catalyst: it opens a window of heightened plasticity and emotional flexibility, which allows therapy to go deeper and integration to become transformative.

Clients who engage in preparation, intention-setting, and post-session integration often experience:

  • Improved emotional insight

  • Reduced reactivity and internal conflict

  • Greater alignment between thoughts, behaviors, and values

  • Increased openness and self-compassion

📚 Supporting study:
Dore, J., Turnipseed, B., et al. (2019). Ketamine-assisted psychotherapy: A qualitative study of patient experiences. Journal of Psychoactive Drugs.
Link

Myth #4: Ketamine Therapy Causes Unpleasant Hallucinations

Ketamine is a dissociative, not a classic psychedelic, and its effects are typically described as dreamlike, reflective, or even peaceful—rather than frightening.

Common sensations during sessions may include:

  • A gentle detachment from the usual inner chatter

  • Heightened sensory awareness

  • A feeling of spaciousness or emotional release

  • Deep introspection or personal insight

Most people find the experience emotionally powerful but manageable, especially when supported by trained therapists in a calm, private setting.

Myth #5: Ketamine Therapy Is Not Evidence-Based

This is a common misconception. In reality, ketamine is one of the most rigorously studied substances in psychedelic medicine.

Highlights from the research:

  • A landmark 2006 study published in Biological Psychiatry found that a single dose of ketamine produced rapid antidepressant effects in patients with treatment-resistant depression.

  • A 2022 meta-analysis in BMJ showed significant efficacy in reducing suicidal ideation.

  • Ongoing studies are evaluating its applications for anxiety, PTSD, OCD, and chronic pain.

More recent research is exploring the synergistic impact of pairing ketamine with structured psychotherapy, showing promise in long-term treatment outcomes.

What Does Psychedelic-Assisted Therapy with Ketamine Look Like?

While each person’s path is unique, a typical journey often includes:

  1. Medical & Psychological Screening
    Ensures safety, suitability, and individualized treatment planning.

  2. Preparation
    Setting goals, building therapeutic rapport, and exploring intentions.

  3. Session Support
    Clients engage in carefully guided sessions with licensed therapists. The environment is calm, private, and trauma-informed.

  4. Integration
    Post-session therapy helps make sense of the experience, drawing connections between insight and everyday life.

A Note on Pain, Emotion, and the Mind-Body Connection

Ketamine is being studied not only for mental health conditions, but also for its potential to reduce chronic pain sensitivity—particularly when pain is compounded by emotional distress or trauma.

By modulating both sensory and affective pathways, it may help clients “unhook” from pain loops that traditional medications can’t fully address.

This emerging area of care is particularly relevant for clients with:

  • Fibromyalgia

  • Complex regional pain syndrome (CRPS)

  • Migraine disorders

  • Somatic symptoms linked to trauma

Conclusion: Informed Curiosity > Misinformation

Ketamine is not a magic pill. But when used responsibly—within a therapeutic context, by trained professionals—it can be a powerful tool in helping people reconnect with themselves, regain clarity, and rediscover hope.

Misconceptions can keep people away from resources that might truly help. That’s why we’re committed to education, transparency, and client-centered care that honors your story.

If you’re exploring whether psychedelic-assisted therapy might be right for you, we invite you to connect. Ask questions. Learn more. The first step is a conversation.

Explore Your Options with Flowstate Therapy

Located in the heart of Ottawa, Flowstate Therapy offers professional, trauma-informed care with clinicians trained in psychedelic-assisted psychotherapy and integration. We work with clients across Canada who are seeking new ways to heal, grow, and reconnect with themselves.

📞 Book a free consultation
📍 171 Nepean Street, Unit 600 – Ottawa, ON
🌐 flowstatetherapy.ca

Previous
Previous

Neurofeedback Therapy in Ottawa

Next
Next

The Essential Role of Therapy in Psychedelic-Assisted Mental Health Care